The Commerce Department is probing whether ripe olives from Spain are being “dumped” at artificially low prices in the US, hurting Central Valley olive growers.
“The Department of Commerce will ensure a full and fair assessment of the facts, and, if the rules are being broken, will act swiftly to halt any unfair trade practices,” said US Secretary of Commerce Wilbur Ross.
The investigations are based on petitions filed by the Coalition for Fair Trade in Ripe Olives, whose individual members are Musco Family Olive Company of Tracy and Bell-Carter Foods of Walnut Creek.
The estimated dumping margins alleged by the petitioners, the proportion by which the commercial value exceeds the export price, are 78% and 223%.
In the investigation, the Commerce Department will determine whether imports of ripe olives from Spain are being dumped in the US market at less than fair value.
In a second investigation, the Commerce Department will determine whether Spanish producers of ripe olives are receiving unfair government subsidies.
If the Commerce Department determines that Spanish ripe olives are being dumped into the US market, and/or receiving unfair government subsidies, and if the US International Trade Commission determines that dumped and/or unfairly subsidized US imports of ripe olives from Spain are causing injury to the US industry, the Commerce Department will impose duties on those imports in the amount of dumping and/or unfair subsidization found to exist.
Full Content: El Diario
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas